ArticleNeoplasia (New York, N.Y.)2019

Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein.

Hidetsugu Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.